INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
CA

Campbell David Alan

Director, President and CEOCIK 0001864158

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score39
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
39
CA
Campbell David AlanDirector, President and CEO
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$111K
8,072 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Janux Therapeutics, Inc.Director, President and CEO · Jan 2, 2026
17
CA
Campbell David AlanDirector, President and CEO
JANXJanux Therapeutics, Inc.
Grant or award
A
—
96.6K sh
Jan 2, 2026
Jan 2, 2026
traded Jan 2, 2026
+0d
SEC FORM 4

Evidence

9
CA
Campbell David AlanDirector, President and CEO
JANXJanux Therapeutics, Inc.
Grant or award
A—
338.1K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC FORM 4

Evidence